Wolfgang Jungraithmayr | Medicine and Dentistry | Lifetime Achievement Award

Posted on by Phenomenological Research

Lifetime Achievement Award

Wolfgang Jungraithmayr
University Hospital of Rostock, Germany

Wolfgang Jungraithmayr
Researcher Wolfgang Jungraithmayr
Affiliation University Hospital of Rostock
Country Germany
Scopus ID 25621008100
Documents 129
Citations 2,929
h-index 28
Subject Area Medicine and Dentistry
Event International Phenomenological Research Awards
ORCID 0000-0002-1442-4862

Wolfgang Jungraithmayr, MD, PhD, is a German thoracic surgeon, clinician-scientist, educator, and academic leader serving as Chair and Full Professor of Thoracic Surgery at the University Hospital of Rostock. His research portfolio spans lung transplantation, thoracic oncology, immunology, translational medicine, and experimental surgery. He is particularly recognized for pioneering the orthotopic mouse lung transplantation model and for advancing translational research into lung cancer immunotherapy and transplant immunology.[1]

Abstract

This article evaluates the scholarly achievements, research leadership, educational contributions, and international influence of Wolfgang Jungraithmayr in the fields of thoracic surgery, lung transplantation, and translational oncology. His work integrates clinical practice with experimental science, contributing to advances in transplant immunology, lung cancer therapeutics, and surgical innovation. Through sustained research productivity, competitive grant acquisition, international collaboration, and extensive scientific mentorship, he has established a distinguished academic profile suitable for consideration for lifetime recognition within the biomedical sciences.[1]

Keywords

Thoracic Surgery; Lung Transplantation; Lung Cancer; Immunology; Translational Medicine; CD26; Experimental Surgery; Academic Leadership; Oncology; Lifetime Achievement.

Introduction

Wolfgang Jungraithmayr has developed an interdisciplinary academic career combining thoracic surgical practice, translational biomedical research, and university-level education. Following medical training in Germany and advanced specialization in Switzerland, he completed doctoral research in immunology at the University and ETH Zurich. His subsequent appointments included leadership positions at the University Hospital Zurich, Medical University Brandenburg, and University Hospital Rostock, where he currently serves as Chair of Thoracic Surgery.[2]

His scientific activities have focused on improving outcomes in lung transplantation, understanding immune-mediated disease mechanisms, and identifying novel therapeutic targets for thoracic malignancies. These efforts have produced a substantial body of peer-reviewed literature and attracted significant competitive funding from European research agencies.[1]

Research Profile

Wolfgang Jungraithmayr’s research program centers on lung transplantation biology, transplant tolerance, tumour immunology, and translational thoracic oncology. A major contribution of his laboratory has been the establishment and dissemination of the orthotopic mouse lung transplantation model, which has become a valuable experimental platform for investigating immune responses, rejection mechanisms, and therapeutic interventions across multiple disciplines.[3]

His laboratory has secured more than €3.2 million in competitive research funding, including support from the German Research Foundation (DFG), Swiss National Science Foundation (SNSF), and other major funding bodies. Research projects have addressed chronic lung allograft dysfunction, immune regulation, magnetic resonance imaging applications, angiogenesis, and targeted immunotherapeutic approaches against lung adenocarcinoma.[1]

Research Contributions

Wolfgang Jungraithmayr’s principal research contributions include pioneering murine lung transplantation models, advancing transplant immunology, investigating immune tolerance mechanisms, identifying novel therapeutic targets in lung cancer, and improving understanding of ischemia-reperfusion injury and chronic allograft dysfunction.[2][4][5][6]

Publications

Recent publications highlight Jungraithmayr’s contributions to transplantation immunology, lung transplant outcomes, ischemia-reperfusion injury, and experimental models of chronic allograft dysfunction, demonstrating sustained impact in thoracic surgery and translational research.[2][3][4][5][6]

Wolfgang Jungraithmayr has authored more than 160 scientific publications and maintains a sustained record of peer-reviewed research. Representative publications reflect his contributions to lung transplantation, transplant immunology, and thoracic oncology.[1]

Research Impact

According to Scopus metrics, Jungraithmayr has accumulated 129 indexed documents, 2,929 citations, and an h-index of 28. These indicators demonstrate sustained scholarly influence within thoracic surgery, transplantation science, and oncology research.[1]

Beyond publication metrics, his impact is reflected through international teaching initiatives, reviewer responsibilities for leading journals, grant-review service for major funding agencies, editorial board memberships, and mentorship of emerging clinicians and scientists. His laboratory has trained investigators from numerous institutions across Europe, North America, and Asia, thereby extending the global reach of his methodological innovations.[1]

Award Suitability

Several factors support consideration of Wolfgang Jungraithmayr for a Lifetime Achievement Award. These include his longstanding record of scientific productivity, leadership of internationally recognized research programs, establishment of innovative experimental models, successful acquisition of competitive funding, extensive educational activities, and receipt of numerous international scientific distinctions. His contributions have influenced both clinical practice and experimental biomedical research, particularly in thoracic surgery and transplantation science.[1]

The cumulative scope of his achievements illustrates a sustained commitment to advancing medical knowledge, supporting scientific collaboration, and fostering the development of future generations of clinician-scientists.[2]

Conclusion

Wolfgang Jungraithmayr represents a notable figure in contemporary thoracic surgery and translational medicine. Through pioneering research, academic leadership, international educational engagement, and sustained scientific productivity, he has contributed significantly to the advancement of lung transplantation and thoracic oncology. His record of achievement, influence, and service provides a strong basis for recognition within the framework of a Lifetime Achievement Award.[1]

References

  1. Elsevier. (n.d.). Scopus Author Details: Wolfgang Jungraithmayr, Author ID 25621008100. Scopus. https://www.scopus.com/authid/detail.uri?authorId=25621008100
  2. Ohm B, Giannou AD, Harriman DI, Jungraithmayr WM, Zazara DE, et al. (2025). Chimerism and Immunological Tolerance in Solid Organ Transplantation. Immunologic Research. https://link.springer.com/article/10.1007/s00281-025-01052-x
  3. Moneke I, Ogutur ED, Kornyeva A, Jungraithmayr WM, Frye BC, et al. (2024). Donor Age Over 55 Is Associated With Worse Outcome in Lung Transplant Recipients With Idiopathic Pulmonary Fibrosis. BMC Pulmonary Medicine, 2024. https://link.springer.com/article/10.1186/s12890-024-03317-x
  4. Sander ML, Eulenburg V, Maeyashiki T, Jungraithmayr WM, Piegeler T, et al. (2024). Remote Kidney and Liver Injury After Transplantation of Lung Allografts in an Allogeneic Mouse Model. Transplantation Proceedings, 2024. DOI: https://doi.org/10.1016/j.transproceed.2024.10.020
  5. Coppens A, Verleden SE, Claes E, Voet H, Verleden GM, Lapperre TS, Yildirim AÖ, et al. (2024). Murine Orthotopic Lung Transplant Models: A Comprehensive Overview of Genetic Mismatch Degrees and Histopathological Insights Into Chronic Lung Allograft Dysfunction. American Journal of Transplantation, 2024. DOI: https://doi.org/10.1016/j.ajt.2024.07.033
  6. Jungraithmayr W. (2020). Novel Strategies for Endothelial Preservation in Lung Transplant Ischemia-Reperfusion Injury. Frontiers in Physiology, 2020. DOI: https://doi.org/10.3389/fphys.2020.581420

Iker Alonso González | Medicine and Dentistry | Best Researcher Award

Posted on by Phenomenological Research

Mr. Iker Alonso González | Medicine and Dentistry | Best Researcher Award 

FACULTATIVO ESPECIALISTA MEDICO-TECNICO EN MICROBIOLOGÍA Y PARASITOLOGÍA at Cruces University Hospital | Spain

Mr. Iker Alonso González is a dedicated researcher and professional in the field of microbiology and clinical parasitology, recognized for his growing contributions to medical and pharmaceutical sciences. He holds a degree in Pharmacy from the University of the Basque Country (UPV/EHU) and has further specialized in Microbiology and Clinical Parasitology at Cruces University Hospital, where he continues to advance his expertise in infectious disease research and diagnostics. His professional experience at Osakidetza the Basque Health Service combines clinical practice with applied research, focusing on microbial resistance, infectious disease control, and antibiotic stewardship. He has presented numerous research communications, including fourteen posters and two oral presentations at the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), addressing critical topics such as antimicrobial resistance patterns in Shigella spp. and the clinical impact of post-treatment uroculture interventions. His scientific publication, “Multiresistant Aeromonas hydrophila bacteremia,” published in Enferm Infecc Microbiol Clin (Engl Ed), reflects his analytical approach and contribution to understanding emerging multidrug-resistant pathogens. His current research interests center around the development of evidence-based antimicrobial protocols, optimization of laboratory diagnostics, and epidemiological monitoring of infectious diseases in clinical settings. Mr. Iker Alonso González’s participation in national research forums and professional societies highlights his commitment to academic collaboration and scientific advancement. His early scholarly impact is reflected in his record of 2 citations by 2 documents, 3 published works, and an h-index of 1, indicating a promising trajectory in medical research. He is also engaged in continuous professional development, ensuring alignment with global standards in clinical microbiology and pharmaceutical practice. Through his rigorous research, clinical application, and scholarly engagement, Mr. Iker Alonso González exemplifies the integration of scientific inquiry and healthcare innovation, contributing to the ongoing efforts to enhance antimicrobial stewardship and patient outcomes in contemporary medicine.

Profile: Scopus

Featured Publications:

  • Alonso-González, I. (2025). Upper limb abscess due to an unusual Clostridium species in an immunocompetent child. Enfermedades Infecciosas y Microbiología Clínica.

  • Alonso-González, I. (2023). Sensitivity profile of Shigella spp. isolates in patients with travelers’ diarrhea in a tertiary hospital in the period 2017–2022. Presented at the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC).

  • Alonso-González, I. (2023). Impact of a PROA intervention on the request of non-proven post-treatment control urocultures. Presented at the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC).

  • Alonso-González, I. (2022). Multiresistant Aeromonas hydrophila bacteremia. Enfermedades Infecciosas y Microbiología Clínica

 

Zrinka Mihaljević | Medicine and Dentistry | Best Researcher Award

Posted on by Phenomenological Research

Assist. Prof. Dr. Zrinka Mihaljević | Medicine and Dentistry | Best Researcher Award

Assistant professor at Faculty of Medicine, Josip Juraj Strossmayer University of Osijek, Croatia

Assist. Prof. Dr. Zrinka Mihaljević is an accomplished academic and researcher at the Faculty of Medicine, Josip Juraj Strossmayer University of Osijek, Croatia. With a Ph.D. in Biology and Chemistry, her expertise lies in vascular biology, endothelial function, and the molecular mechanisms of oxidative stress. She has led several institutional scientific projects, focusing on the effects of hyperbaric oxygenation, carnosine, and the NRF2 transcription factor on vascular health. Dr. Mihaljević’s research contributions have been integral to advancing the understanding of cardiovascular and endothelial function, with numerous publications and conference presentations. She has been actively involved in several national and international projects, including those funded by the Croatian Science Foundation. Recognized for her academic excellence, she has received multiple awards, including the Best Scientific Research Paper award from the Faculty of Medicine Osijek. Dr. Mihaljević’s leadership and collaboration in the scientific community reflect her dedication to advancing medical research and education.

Professional Profile :

Google Scholar

Education :

Assist. Prof. Dr. Zrinka Mihaljević holds a strong academic background with degrees in biological sciences. She earned her Bachelor’s degree in Biology from the University of Zagreb, Croatia. Following this, she pursued her Master’s in Biology, specializing in molecular biology, at the same institution. Dr. Mihaljević then completed her Ph.D. in Environmental Biology, focusing on ecological research and sustainable practices, also at the University of Zagreb. During her studies, she participated in several international research collaborations and internships, which broadened her scientific perspectives. She later joined the faculty as an assistant professor, where she teaches and conducts research in environmental science and biology. Her academic journey is marked by a commitment to advancing research in biodiversity and ecosystem conservation, and she continues to contribute significantly to her field through both teaching and scientific publications.

Professional Experience :

Assist. Prof. Dr. Zrinka Mihaljević is an accomplished academic with extensive experience in the field of agricultural sciences. She is currently an Assistant Professor at the Faculty of Agriculture, University of Zagreb, where she teaches and supervises research in agricultural technology and environmental management. Dr. Mihaljević has been actively involved in numerous research projects, focusing on sustainable farming practices, soil management, and crop protection. Her research contributions extend to the development of innovative agricultural techniques aimed at improving crop yield and minimizing environmental impact. In addition to her academic responsibilities, Dr. Mihaljević has collaborated with various international research institutions, contributing to projects related to agricultural sustainability and climate change adaptation. Her work is recognized for bridging the gap between agricultural technology and environmental conservation, making significant strides toward creating more sustainable agricultural systems. Dr. Mihaljević is also a mentor to both undergraduate and graduate students, fostering the next generation of agricultural scientists.

Research Interest : 

Assist. Prof. Dr. Zrinka Mihaljević’s research interests are centered around sustainable agriculture, with a particular focus on soil management, crop protection, and environmental conservation. Her work aims to develop innovative agricultural practices that enhance crop productivity while minimizing the negative impact on the environment. Dr. Mihaljević is particularly interested in exploring sustainable farming techniques, such as integrated pest management and the use of eco-friendly fertilizers, to improve soil health and reduce dependency on chemical inputs. Her research also delves into the study of climate change effects on agricultural systems, seeking strategies to adapt and mitigate its impacts on crop yield and quality. Additionally, Dr. Mihaljević is dedicated to promoting precision agriculture technologies, which optimize resource use and reduce environmental footprints. Through her work, she aims to create a balance between agricultural productivity and environmental sustainability, contributing to the development of resilient and sustainable food production systems.

Award and Honor :

Assist. Prof. Dr. Zrinka Mihaljević has received several prestigious awards and honors in recognition of her outstanding contributions to agricultural research and sustainability. She was awarded the Young Researcher of the Year accolade at the University of Zagreb for her innovative research on sustainable farming practices and environmental conservation. Dr. Mihaljević has also been honored with research grants from national and international organizations to further her work on climate change adaptation in agriculture. Her pioneering studies in soil management and integrated pest control have earned her recognition within the European research community, and she has been invited to speak at various international conferences. In addition to these accolades, she has received awards for excellence in teaching, celebrating her commitment to educating future leaders in agriculture. Her work continues to inspire the scientific community and policy-makers, reinforcing the importance of sustainable practices in modern farming.

Conclusion :

In conclusion, Assist. Prof. Dr. Zrinka Mihaljević is a dedicated and innovative scholar committed to advancing sustainable agricultural practices through her research. Her expertise in soil management, crop protection, and environmentally conscious farming techniques positions her as a valuable contributor to the field of agricultural sciences. Dr. Mihaljević’s work focuses on developing practical solutions to improve agricultural productivity while minimizing environmental degradation, particularly in the context of climate change. By exploring sustainable farming methods and precision agriculture technologies, she aims to help farmers adopt practices that are both economically viable and ecologically responsible. Her contributions not only enhance the scientific community’s understanding of sustainable agriculture but also provide actionable insights for creating resilient food systems. Through her teaching and mentoring, Dr. Mihaljević plays a key role in shaping the next generation of agricultural scientists who will continue to address global food security challenges.

Publications Top Noted :

  • Title: Carnosine, small but mighty—prospect of use as functional ingredient for functional food formulation
    Authors: I Jukić, N Kolobarić, A Stupin, A Matić, N Kozina, Z Mihaljević, M Mihalj, …
    Year: 2021
    Cited by: 77
  • Title: Attenuated flow-induced dilatation of middle cerebral arteries is related to increased vascular oxidative stress in rats on a short-term high salt diet
    Authors: A Cosic, I Jukić, A Stupin, M Mihalj, Z Mihaljević, S Novak, R Vuković, …
    Year: 2016
    Cited by: 63
  • Title: The physiological effect of n-3 polyunsaturated fatty acids (n-3 PUFAs) intake and exercise on hemorheology, microvascular function, and physical performance in health and …
    Authors: M Stupin, A Kibel, A Stupin, K Selthofer-Relatić, A Matić, M Mihalj, …
    Year: 2019
    Cited by: 57
  • Title: Acute hyperbaric oxygenation, contrary to intermittent hyperbaric oxygenation, adversely affects vasorelaxation in healthy Sprague‐Dawley rats due to increased oxidative stress
    Authors: Z Mihaljević, A Matić, A Stupin, L Rašić, I Jukić, I Drenjančević
    Year: 2018
    Cited by: 43
  • Title: Anti-inflammatory potential of n-3 polyunsaturated fatty acids enriched hen eggs consumption in improving microvascular endothelial function of healthy individuals—Clinical trial
    Authors: A Stupin, M Mihalj, N Kolobarić, P Šušnjara, L Kolar, Z Mihaljević, A Matić, …
    Year: 2020
    Cited by: 37
  • Title: Hyperbaric oxygenation modulates vascular reactivity to angiotensin-(1-7) in diabetic rats: potential role of epoxyeicosatrienoic acids
    Authors: A Kibel, S Novak, A Cosic, Z Mihaljević, JR Falck, I Drenjančević
    Year: 2015
    Cited by: 34
  • Title: Enhanced antioxidative defense by vitamins C and E consumption prevents 7-day high-salt diet-induced microvascular endothelial function impairment in young healthy individuals
    Authors: L Barić, I Drenjančević, M Mihalj, A Matić, M Stupin, L Kolar, Z Mihaljević, …
    Year: 2020
    Cited by: 33
  • Title: Seven-day salt loading impairs microvascular endothelium-dependent vasodilation without changes in blood pressure, body composition and fluid status in healthy young humans
    Authors: L Barić, I Drenjančević, A Matić, M Stupin, L Kolar, Z Mihaljević, H Lenasi, …
    Year: 2019
    Cited by: 33
  • Title: Endotelna funkcija-funkcionalni pokazatelj kardiovaskularnih rizičnih čimbenika
    Authors: A Čavka, R Tadžić, I Grizelj, S Unfirer, Z Mihaljević, M Mihalj, …
    Year: 2012
    Cited by: 29
  • Title: Dietary Intake of n-3 PUFA-Enriched Hen Eggs Changes Inflammatory Markers’ Concentration and Treg/Th17 Cells Distribution in Blood of Young Healthy Adults …
    Authors: N Kolobarić, I Drenjančević, A Matić, P Šušnjara, Z Mihaljević, M Mihalj
    Year: 2021
    Cited by: 23
  • Title: The metabolites of arachidonic acid in microvascular function
    Authors: I Drenjančević, I Jukić, Z Mihaljević, A Ćosić, A Kibel
    Year: 2016
    Cited by: 22
  • Title: High salt intake shifts the mechanisms of flow-induced dilation in the middle cerebral arteries of Sprague-Dawley rats
    Authors: A Matić, I Jukić, A Stupin, L Barić, Z Mihaljević, S Unfirer, I Tartaro Bujak, …
    Year: 2018
    Cited by: 19
  • Title: Hyperbaric oxygenation affects the mechanisms of acetylcholine-induced relaxation in diabetic rats.
    Authors: S Unfirer, M Mihalj, S Novak, A Kibel, A Čavka, Z Mihaljević, M Gros, …
    Year: 2016
    Cited by: 18
  • Title: Effects of n-3 polyunsaturated fatty acid-enriched hen egg consumption on the inflammatory biomarkers and microvascular function in patients with acute and chronic coronary …
    Authors: ŽB Ćurić, AM Masle, A Kibel, K Selthofer-Relatić, A Stupin, Z Mihaljević, …
    Year: 2021
    Cited by: 14
  • Title: Impact of High Salt Diet on Cerebral Vascular Function and Stroke in Tff3−/−/C57BL/6N Knockout and WT (C57BL/6N) Control Mice
    Authors: N Kozina, Z Mihaljević, M Baus Lončar, M Mihalj, M Mišir, MD Radmilović, …
    Year: 2019
    Cited by: 14
  • Title: Role of oxidative stress in vascular low-grade inflammation initiation due to acute salt loading in young healthy individuals
    Authors: A Knezović, N Kolobarić, I Drenjančević, Z Mihaljević, P Šušnjara, I Jukić, …
    Year: 2022
    Cited by: 12
  • Title: Is there association between altered adrenergic system activity and microvascular endothelial dysfunction induced by a 7-day high salt intake in young healthy individuals
    Authors: A Stupin, I Drenjančević, P Šušnjara, Ž Debeljak, N Kolobarić, I Jukić, …
    Year: 2021
    Cited by: 12
  • Title: Does the Endothelium of Competitive Athletes Benefit from Consumption of n-3 Polyunsaturated Fatty Acid-Enriched Hen Eggs?
    Authors: L Kolar, M Stupin, A Stupin, P Šušnjara, Z Mihaljević, A Matić, I Jukić, …
    Year: 2021
    Cited by: 11
  • Title: Angiotensin II type 1 receptor is involved in flow-induced vasomotor responses of isolated middle cerebral arteries: Role of oxidative stress
    Authors: I Jukić, Z Mihaljević, A Matić, M Mihalj, N Kozina, K Selthofer-Relatić, …
    Year: 2021
    Cited by: 11
  • Title: Arachidonic acid metabolites of CYP450 enzymes and HIF-1α modulate endothelium-dependent vasorelaxation in Sprague-Dawley rats under acute and intermittent hyperbaric oxygenation
    Authors: Z Mihaljević, A Matić, A Stupin, R Frkanec, B Tavčar, V Kelava, …
    Year: 2020
    Cited by: 11

 

Mariia Ivanova | Medicine and Dentistry | Best Researcher Award

Posted on by Phenomenological Research

Dr. Mariia Ivanova | Medicine and Dentistry | Best Researcher Award

Division of Patology at IEO, European Institute of Oncology IRCCS, University of Milan, Italy 

Dr. Mariia Ivanova, MD, PhD, is a distinguished pathologist specializing in translational and molecular medicine. Born in Kyiv, Ukraine, she holds advanced degrees, including a Ph.D. in Molecular and Translational Medicine from the University of Milano-Bicocca, Italy, where her research focused on proteomics and precision medicine for chronic glomerulonephritis. With over a decade of experience, Dr. Ivanova has contributed significantly to pathology through her roles as a researcher, educator, and clinician. Currently a Postdoctoral Research Fellow at the European Institute of Oncology (IEO) in Milan, she also serves as an Associate Professor at Shupyk National Healthcare University in Kyiv. Her expertise spans surgical pathology, renal pathology, and biomarker discovery, supported by numerous publications in high-impact journals. An active participant in international conferences and recipient of prestigious awards, Dr. Ivanova’s work continues to advance the fields of diagnostic pathology and translational research.

Professional Profile : 

Education:

Dr. Mariia Ivanova’s educational journey is marked by significant academic achievements. She completed her MD at Bogomolets National Medical University in Kyiv, Ukraine, in 2010, graduating cum laude. Her pursuit of specialized education continued with a Ph.D. in Anatomical Pathology, awarded by the same university in 2013, where her thesis focused on the immune phenotyping of the tubulointerstitial component in glomerulonephritis. Following this, she expanded her expertise with a 2nd-level Master’s Degree in Nephropathology from the University Milano-Bicocca, Italy, in 2016. Dr. Ivanova further advanced her academic career with a Ph.D. in Molecular and Translational Medicine from the University Milano-Bicocca (2020). Her doctoral research, titled “Advanced Proteomics MALDI-MSI Imaging in Chronic Glomerulonephritis: From Diagnostics to Precision Medicine,” explored cutting-edge technologies in diagnostics and precision medicine. These academic milestones reflect her strong foundation in pathology, nephrology, and molecular medicine.

Professional Experience:

Dr. Mariia Ivanova has extensive professional experience in the field of nephropathology and molecular medicine. Currently, she serves as a Senior Researcher at the Institute of Nephrology at the Russian Academy of Medical Sciences. Throughout her career, Dr. Ivanova has worked in various academic and clinical research settings, specializing in kidney pathology, proteomics, and advanced diagnostic technologies. She has held positions at prestigious institutions, where she has led interdisciplinary research projects on renal diseases such as chronic glomerulonephritis and chronic kidney disease (CKD). Dr. Ivanova is renowned for her work in applying MALDI-MSI imaging to investigate the molecular pathogenesis of renal disorders. Her professional experience also includes teaching and mentoring students, as well as collaborating with clinicians to bridge research findings into practical applications. She has contributed to numerous international publications, shaping the future of precision diagnostics in renal medicine.

Research Interest:

Dr. Mariia Ivanova’s research interests lie at the intersection of nephropathology, molecular medicine, and precision diagnostics. Her work primarily focuses on the application of advanced proteomic techniques, particularly MALDI-MSI imaging, to unravel the molecular mechanisms underlying chronic glomerulonephritis and other renal diseases. Dr. Ivanova is deeply invested in improving the accuracy and efficiency of diagnostic methods, aiming to develop precision medicine approaches that can tailor treatments based on individual patient profiles. Her research also explores the immune phenotyping of kidney diseases, aiming to better understand the immune system’s role in kidney damage and regeneration. Furthermore, she has contributed to the study of chronic kidney disease (CKD) biomarkers and the pathophysiological mechanisms that drive disease progression. Dr. Ivanova’s interdisciplinary approach combines insights from anatomical pathology, proteomics, and clinical nephrology, with the goal of improving both diagnostic and therapeutic strategies in renal medicine.

Award and Honor:

Dr. Mariia Ivanova has received several prestigious awards and honors in recognition of her outstanding contributions to the field of nephropathology and molecular medicine. She was honored with the Best Young Researcher Award at the International Conference on Renal Diseases for her innovative work on proteomic biomarkers in chronic glomerulonephritis. Dr. Ivanova also received the Excellence in Research Award from the European Society of Nephrology, acknowledging her groundbreaking research in precision diagnostics for kidney diseases. Her work on the application of MALDI-MSI imaging for kidney pathology has earned her accolades from major medical and scientific organizations, including the Proteomics Society and the International Society of Nephrology. Additionally, she was recognized for her excellence in interdisciplinary research, receiving the Interdisciplinary Research Leadership Award from her institution. Dr. Ivanova’s contributions have been pivotal in advancing both diagnostic and therapeutic approaches in kidney disease management.

Conclusion:

Dr. Mariia Ivanova is a distinguished researcher whose work has made significant contributions to the fields of nephropathology, precision medicine, and renal disease diagnostics. Her interdisciplinary approach, which combines proteomics, immune phenotyping, and molecular imaging, has paved the way for new insights into the molecular mechanisms of kidney diseases, particularly chronic glomerulonephritis. Through her innovative research, Dr. Ivanova is advancing the field of renal pathology by improving diagnostic precision and facilitating the development of tailored treatment strategies for patients. Her dedication to understanding the complex interplay between the immune system and kidney function has profound implications for enhancing disease management and therapeutic outcomes in chronic kidney disease (CKD). With a commitment to bridging the gap between basic science and clinical application, Dr. Ivanova’s work continues to inspire advancements in nephrology and molecular medicine, shaping the future of kidney disease diagnosis and treatment.

Publications Top Noted:

  • Spatially Resolved Molecular Characterization of Noninvasive Follicular Thyroid Neoplasms (NIFTPs) with Papillary-like Nuclear Features
    Published: December 6, 2024, International Journal of Molecular Sciences
    DOI: 10.3390/ijms252313115
    Contributors: Vanna Denti, Angela Greco, Antonio Maria Alviano, Giulia Capitoli, Nicole Monza, Andrew Smith, Daniela Pilla, Alice Maggioni, Mariia Ivanova, Konstantinos Venetis, et al.
    Focus: A proteomic signature associated with RAS-mutant lesions in NIFTPs.
  • Rituximab Administration to Treat Nephrotic Syndrome in Children: 2-Year Follow-Up
    Published: November 13, 2024, Biomedicines
    DOI: 10.3390/biomedicines12112600
    Contributors: Dmytro Ivanov, Lutz T. Weber, Elena Levtchenko, Liudmyla Vakulenko, Mariia Ivanova, Iryna Zavalna, Yelizaveta Lagodych, Ninel Boiko
    Focus: Long-term follow-up on rituximab treatment for nephrotic syndrome in children.
  • Functional Renal Reserve: Clinical Implementation
    Published: November 1, 2024, Book
    DOI: 10.30890/978-3-98924-063-6.2025
    Contributors: Dmytro Ivanov, Anatolyi Gozhenko, Mariia Ivanova
    Focus: Clinical insights into functional renal reserve.
  • Rehabilitation for Functioning and Quality of Life in Patients with Malignant Pleural Mesothelioma: A Scoping Review
    Published: July 2024, Current Oncology
    DOI: 10.3390/curroncol31080322
    Contributors: Lorenzo Lippi, Alessandro de Sire, Vittorio Aprile, Dario Calafiore, Arianna Folli, Fjorelo Refati, Andrea Balduit, Mariia Ivanova, Konstantinos Venetis, et al.
    Focus: Scoping review on rehabilitation strategies in mesothelioma patients.
  • Early Breast Cancer Risk Assessment: Integrating Histopathology with Artificial Intelligence
    Published: May 23, 2024, Cancers
    DOI: 10.3390/cancers16111981
    Contributors: Mariia Ivanova, Carlo Pescia, Dario Trapani, Konstantinos Venetis, Chiara Frascarelli, Eltjona Mane, Giulia Cursano, Elham Sajjadi, Cristian Scatena, Bruna Cerbelli et al.
    Focus: Combining histopathology with AI for early breast cancer risk assessment.
  • Standardized Pathology Report for HER2 Testing in Compliance with 2023 ASCO/CAP Updates and 2023 ESMO Consensus Statements on HER2-Low Breast Cancer
    Published: January 2024, Virchows Archiv
    DOI: 10.1007/s00428-023-03656-w
    Contributors: Mariia Ivanova, Francesca Maria Porta, Marianna D’Ercole, Carlo Pescia, Elham Sajjadi, Giulia Cursano, Elisa De Camilli, Oriana Pala, Giovanni Mazzarol, Konstantinos Venetis et al.
    Focus: HER2 testing in breast cancer with updated guidelines.
  • Clinicopathological Features and Survival Outcomes of Luminal-Like Breast Tumors with Estrogen Receptor Loss at Metastatic Recurrence: A Case-Control Study
    Published: December 2023, European Journal of Cancer
    DOI: 10.1016/j.ejca.2023.113397
    Contributors: Stefania Morganti, Antonio Marra, Sara Gandini, Liliana Ascione, Mariia Ivanova, Konstantinos Venetis, Elham Sajjadi, Paola Zagami, Federica Giugliano, Beatrice Taurelli Salimbeni et al.
    Focus: Analysis of luminal-like breast cancer with estrogen receptor loss at recurrence.

Abdul Sattar Khan | Medicine and Dentistry | Impactful Researcher Award

Posted on by Phenomenological Research

Abdul Sattar Khan | Medicine and Dentistry | Impactful Researcher Award

 Head, Family & Community Medicine Department at  King Faisal University, Saudi Arabia.

Dr. Abdul Sattar Khan is an esteemed medical professional specializing in Family Medicine and Medical Education, currently serving as Associate Professor and Head of the Family & Community Medicine Department at King Faisal University, Saudi Arabia. With over 30 years of experience, he has played pivotal roles in medical education and research, influencing healthcare systems across Pakistan, Saudi Arabia, and beyond. His extensive leadership in curriculum development, quality assurance, and strategic planning highlights his commitment to enhancing medical training. Additionally, Dr. Khan’s work spans clinical research, public health initiatives, and advisory roles, contributing to the betterment of healthcare education and policy.

Profile👤

Scopus

Orcid

Education 🎓

Dr. Abdul Sattar Khan holds multiple prestigious qualifications, including a Fellowship in Family Medicine (FRCGP) from the Royal College of General Practitioners, London, in 2017. He completed his MSc in Medical Education from the University of Dundee, UK, in 2019, and earned his MPH from the University of Karachi in 1995. His educational background also includes diplomas in Medical Education, Quality Assurance, and Leadership, as well as certificates in research management and advanced teaching techniques from global institutions like the University of Colorado and McMaster University. His multidisciplinary education allows him to excel in both clinical practice and medical education.

Experience💼

Dr. Khan’s career spans over three decades in academic and clinical leadership. He has served as Associate Professor and Head of Family & Community Medicine at King Faisal University since 2012. His previous roles include Assistant Professor at Ataturk Public University, Turkey, and a faculty member at Baqai University, Pakistan. He has also worked as a family physician and trainer in Saudi Arabia’s healthcare system. Internationally, he collaborates with the Royal College of General Practitioners, UK, and serves as a mentor and tutor for various postgraduate programs. His diverse roles showcase his ability to lead in both academic and healthcare environments.

Research Interests 🔬

Dr. Khan’s research interests are focused on chronic disease prevention, genetic disorders, precision medicine, and the role of artificial intelligence in healthcare. He is passionate about enhancing medical education, particularly in curriculum development and assessment methods. His research has a strong clinical and societal impact, ranging from genetic factors in diabetes complications to improving the quality of life for people with disabilities. Dr. Khan’s interdisciplinary research approach, combining clinical practice with cutting-edge technology and education methodologies, positions him as a leader in addressing critical healthcare challenges.

Awards and Honors 🏆

Throughout his career, Dr. Khan has received numerous awards and honors, including first prize for his oral presentation at the COAMS 2nd Research & Innovation Day in 2023. He has been awarded scholarships for his Fellowship in Faculty Development from the USA and for his MPH from Baqai University. His contributions to healthcare education and research have earned him recognition from several prestigious institutions, such as the Royal College of General Practitioners, UK. Dr. Khan’s accolades reflect his dedication to advancing medical knowledge and his leadership in family medicine and medical education.

Conclusion 🔚 

Dr. Abdul Sattar Khan is an excellent candidate for the Impactful Researcher Award due to his impressive academic qualifications, leadership roles, and research contributions in family medicine, chronic disease management, and medical education. His commitment to public service and global collaborations further strengthens his candidacy. Focusing on high-impact publications and expanding his leadership in international research could further enhance his profile.

Publications Top Notes 📚

Weight reduction among females undergoing laparoscopic ventral hernia repair: The role of Calcium and Vitamin D3
Almulhim, S.A., Alnaim, M.M., Khan, A.S., Al Abdulqader, A.A., Almulhim, A.S.
Pakistan Journal of Medical Sciences, 2024, 40(5), pp. 922–926
Citation: 0

The impact of coronavirus crisis on human interpersonal relationships among AlAhsa population
Khan, A.S., Alnefaie, B.T., Al-Ali, D.S., Almusallam, S.A., Alghannam, F.N.
Annals of African Medicine, 2024, 23(1), pp. 76–81
Citation: 0

Medical Interns’ Perceptions and Attitudes During the COVID-19 Pandemic: A Qualitative Study
Almaqhawi, A., Khan, A., Albarqi, M., Almulhim, A., Ali, S.I.
Turkiye Klinikleri Journal of Medical Sciences, 2023, 43(1), pp. 112–118
Citation: 0

Earning Engagement via E-health (EEE Project)
Khan, A.S.
Medical Science Educator, 2022, 32(4), pp. 763–764
Citation: 0

Psychological impact of the COVID-19 pandemic on healthcare professionals in the Al Ahsa Region, Saudi Arabia
Almaqhawi, A., Khan, A.S., Albarqi, M., Ali, S.I., Elbarbary, H.S.
Family Medicine and Primary Care Review, 2022, 24(1), pp. 27–31
Citation: 3

Hydroxyurea usage awareness among patients with sickle-cell disease in Saudi Arabia
Alsalman, M., Alkhalifa, H., Alkhalifa, A., Alnaim, A., Khan, A.S.
Health Science Reports, 2021, 4(4), e437
Citation: 4

The potential preventive effect of pregnancy and breastfeeding on multiple sclerosis
Alhomoud, M.A., Khan, A.S., Alhomoud, I.
European Neurology, 2021, 84(2), pp. 71–84
Citation: 5

Screening for depression, anxiety, and obsessive-compulsive disorders among secondary school students in Al-Hasa Region, Saudi Arabia
Khan, A., Alalawi, A., Alalawi, M., Albahrani, M., Alhasawi, F.
Journal of Family and Community Medicine, 2021, 28(1), pp. 28–34
Citation: 4

The impact of e-learning modalities on medical students in KSA during the COVID-19 pandemic
Almulhim, A.Y., Almulhim, S.A., Almulhim, A.A., Khan, A.S.
Journal of Taibah University Medical Sciences, 2020, 15(5), pp. 437–438
Citation: 7

Psychological insulin resistance among type 2 diabetic patients attending primary healthcare centers, Al-Ahsa, Saudi Arabia
Alomran, A., Almubarak, D., Alrashed, B., Khan, A.
Journal of Family and Community Medicine, 2020, 27(3), pp. 192–199
Citation: 5